In 2021, roughly 6% of the world's population, or 529 million people, were living with diabetes, mostly type 2 diabetes (T2D) ...

Muscle strength was measured using grip strength relative to fat-free mass, while genetic risk was determined via a polygenic ...

Combination therapy with GLP-1 RAs and thiazolidinediones is associated with a reduced risk for mortality in patients with T2D, a study finds.

Diabetes can be a gateway to other diseases, including heart disease, stroke, dementia, high blood pressure and ...

The FDA warned that several hundred units of counterfeit 1-mg semaglutide (Ozempic) were found in the U.S. drug supply chain ...

The new name and endorsement at the World Diabetes Congress are seen as long-overdue recognition that will spur more research ...

Researchers from the School of Public Health, LKS Faculty of Medicine of the University of Hong Kong (HKUMed) conducted a ...

Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.

The following is a summary of “Evidence for improved glucose metrics and perinatal outcomes with continuous glucose ...

Researchers conducted a large-scale epidemiological study to explore the potential health benefits of high muscle strength in preventing type 2 diabetes (T2D) across varying levels of genetic risk.

A new review finds federally qualified health centers (FQHCs) are underutilized in hypertension and type 2 diabetes clinical research, despite their potential to improve trial diversity.

Diabetic foot screening intervals could be extended beyond 1 year for patients at very low risk for diabetic foot complications.